Overview This page contains the latest trade data of Phenazone (antipyrin), derivatives. In 2022, Phenazone (antipyrin), derivatives were the world's 4103rd most traded product, with a total trade of $102M. Between 2021 and 2022 the exports of Phenazone (antipyrin), derivatives decreased by -31.3%, from $148M to $102M. Trade in Phenazone (antipyrin), derivatives represent 0.00043% of total world trade.
Phenazone (antipyrin), derivatives are a part of Nitrogen Heterocyclic Compounds.
Exports In 2022 the top exporters of Phenazone (antipyrin), derivatives were China ($42.7M), Germany ($25.8M), India ($9.77M), Netherlands ($7.63M), and United States ($2.75M).
Imports In 2022 the top importers of Phenazone (antipyrin), derivatives were Brazil ($16.1M), Romania ($15.8M), Germany ($5.54M), Turkey ($5.05M), and Bulgaria ($4.38M).
Ranking Phenazone (antipyrin), derivatives ranks 1505th in the Product Complexity Index (PCI).
Description Phenazone (antipyrin) is used to treat fever and pain. It was developed in 1912 by the German scientist Heinrich H. E. Backer, and was originally marketed as "Novocaine."